Market Research Report

Global Recto-vaginal Fistula Treatment Market Report By Type (High Recto-vaginal Fistula, Low Recto-vaginal Fistula, Midzone Fistula), By End-user (Hospitals, Ambulatory Surgical Center, Others), By Indication (Crohn's Disease, Delivery-related Injuries, Cancerous Tumor Treatment, Others), By Treatment (Medication, Antibiotics, Biologics Therapy, Surgery, Sphincteroplasty Procedure, Endorectal Advancement Flap Procedure, Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028

ID:VMR11218203
May 2022
Report Formats: Report Formats
The global demand for Recto-vaginal Fistula Treatment Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.

Recto-vaginal fistula is an aberrant epithelial line that connects the rectum and the vagina. A recto-vaginal fistula can be caused by obstetric injuries such as a fourth or third degree perineal tear or prolonged labour with necrosis of the portion or episiotomy. Childbirth can also result in recto-vaginal fistulas. Conditions in the recto-vaginal septum cause the disorder. Bartholin gland infections cause low recto-vaginal fistula and crypto-glandular ano-rectal abscess drains. Hysterectomy is performed because of infection generated owing to fistula. Lymph granuloma venereum with TB might result in recto-vaginal fistula.

Market Dynamics

The global recto-vaginal fistula treatment market is driven by an increase in the prevalence of Crohn's disease, leading to recto-vaginal fistula. Recto-vaginal fistulas are most commonly caused by delivery-related trauma. This can include a perineum tear that spreads to the colon or an episiotomy infection and a surgical cut to expand the perineum after vaginal delivery. These can happen after a long, challenging, or obstructed labour. Damage to the anal sphincter, the muscular rings at the end of the rectum that help a person hold, could also cause a fistula. As a result, due to an increase in the prevalence of delivery traumas, the rate of recto-vaginal fistula treatment is predicted to rise during the forecasted period. Recto-vaginal fistula can develop due to previous surgery in the lower pelvic region, such as hysterectomy.Furthermore, radiation therapy used to treat cancer in these body areas raises the likelihood of recto-vaginal fistulas developing. As a result, the worldwide recto-vaginal fistula treatment market is expected to be driven by increased pelvic cancer and surgery in the lower pelvic region. Governments in developing nations are actively investing in modernising their healthcare infrastructure improving access to healthcare services. As a result, the demand for recto-vaginal fistula treatment is likely to increase.

The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of recto-vaginal fistula treatment. The growth and trends of recto-vaginal fistula treatment industry provide a holistic approach to this study. 

Market Segmentation

This section of the recto-vaginal fistula treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities. 

By Type
  • High Recto-Vaginal Fistula
  • Low Recto-Vaginal Fistula
  • Midzone Fistula

By End-User
  • Hospitals
  • Ambulatory Surgical Center
  • Others

By Indication
  • Crohn'S Disease
  • Delivery-Related Injuries
  • Cancerous Tumor Treatment
  • Others

By Treatment
  • Medication
  • Antibiotics
  • Biologics Therapy
  • Surgery
  • Sphincteroplasty Procedure
  • Endorectal Advancement Flap Procedure
  • Others

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Recto-vaginal Fistula Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

Global Recto-vaginal Fistula Treatment Market Share by Region (Representative Graph)

Global Recto-vaginal Fistula Treatment Market Share
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the recto-vaginal fistula treatment market include Pfizer, Inc., GlaxoSmithKline plc, Sanofi S.A., Takeda Pharmaceutical Company Limited, Johnson & Johnson Services, Inc., W. L. Gore & Associates, Inc., Mount Sinai Hospital, Tubingen University Hospital, St. Mark's Hospital, Apollo Hospitals Enterprise Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

METHODOLOGY:

This market research report has been produced by gathering information based on primary and secondary research. Secondary research has been done using various sources, including (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications. Additionally, our team conducts extensive primary research with key industry participants to gather first-hand data. The data is then analyzed and validated by industry experts.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Frequently Asked Questions (FAQs) about this Report

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Market
       2.2. Global Market Snapshot
 
3 . RECTO-VAGINAL FISTULA TREATMENT – INDUSTRY ANALYSIS
       3.1. Introduction - Market Dynamics
       3.2. Market Drivers
       3.3. Market Restraints
       3.4. Opportunities
       3.5. Industry Trends
       3.6. Porter’s Five Force Analysis
       3.7. Market Attractiveness Analysis
           3.7.1 Market Attractiveness Analysis By Type
           3.7.2 Market Attractiveness Analysis By End-user
           3.7.3 Market Attractiveness Analysis By Indication
           3.7.4 Market Attractiveness Analysis By Treatment
           3.7.5 Market Attractiveness Analysis By Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Value Chain Analysis
       4.2. Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Raw Material Manufactures List
           4.2.3. Price Trend of Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic 
       5.5. COVID-19: Micro and Macro Factor Analysis
 
6 . GLOBAL RECTO-VAGINAL FISTULA TREATMENT MARKET ANALYSIS BY TYPE
       6.1 Overview by Type
       6.2 Historical and Forecast Data
       6.3 Analysis by Type
       6.4 High Recto-vaginal Fistula Historic and Forecast Sales by Regions
       6.5 Low Recto-vaginal Fistula Historic and Forecast Sales by Regions
       6.6 Midzone Fistula Historic and Forecast Sales by Regions
 
7 . GLOBAL RECTO-VAGINAL FISTULA TREATMENT MARKET ANALYSIS BY END-USER
       7.1 Overview by End-user
       7.2 Historical and Forecast Data
       7.3 Analysis by End-user
       7.4 Hospitals Historic and Forecast Sales by Regions
       7.5 Ambulatory Surgical Center Historic and Forecast Sales by Regions
       7.6 Others Historic and Forecast Sales by Regions
 
8 . GLOBAL RECTO-VAGINAL FISTULA TREATMENT MARKET ANALYSIS BY INDICATION
       8.1 Overview by Indication
       8.2 Historical and Forecast Data
       8.3 Analysis by Indication
       8.4 Crohn's Disease Historic and Forecast Sales by Regions
       8.5 Delivery-related Injuries Historic and Forecast Sales by Regions
       8.6 Cancerous Tumor Treatment Historic and Forecast Sales by Regions
       8.7 Others Historic and Forecast Sales by Regions
 
9 . GLOBAL RECTO-VAGINAL FISTULA TREATMENT MARKET ANALYSIS BY TREATMENT
       9.1 Overview by Treatment
       9.2 Historical and Forecast Data
       9.3 Analysis by Treatment
       9.4 Medication Historic and Forecast Sales by Regions
       9.5 Antibiotics Historic and Forecast Sales by Regions
       9.6 Biologics Therapy Historic and Forecast Sales by Regions
       9.7 Surgery Historic and Forecast Sales by Regions
       9.8 Sphincteroplasty Procedure Historic and Forecast Sales by Regions
       9.9 Endorectal Advancement Flap Procedure Historic and Forecast Sales by Regions
       9.10. Others Historic and Forecast Sales by Regions
 
10 . GLOBAL RECTO-VAGINAL FISTULA TREATMENT MARKET ANALYSIS BY GEOGRAPHY
       10.1. Regional Outlook
       10.2. Introduction
       10.3. North America Sales Analysis
           10.3.1. Overview, Historic and Forecast Sales Analysis
           10.3.2. North America By Segment Sales Analysis
           10.3.3. North America By Country Sales Analysis
           10.3.4. United State Sales Analysis
           10.3.5. Canada Sales Analysis
           10.3.6. Mexico Sales Analysis
       10.4. Europe Sales Analysis
           10.4.1. Overview, Historic and Forecast Sales Analysis
           10.4.2. Europe by Segment Sales Analysis
           10.4.3. Europe by Country Sales Analysis
           10.4.4. United Kingdom Sales Analysis
           10.4.5. France Sales Analysis
           10.4.6. Germany Sales Analysis
           10.4.7. Italy Sales Analysis
           10.4.8. Russia Sales Analysis
           10.4.9. Rest Of Europe Sales Analysis
       10.5. Asia Pacific Sales Analysis
           10.5.1. Overview, Historic and Forecast Sales Analysis
           10.5.2. Asia Pacific by Segment Sales Analysis
           10.5.3. Asia Pacific by Country Sales Analysis
           10.5.4. China Sales Analysis
           10.5.5. India Sales Analysis
           10.5.6. Japan Sales Analysis
           10.5.7. South Korea Sales Analysis
           10.5.8. Australia Sales Analysis
           10.5.9. Rest Of Asia Pacific Sales Analysis
       10.6. Latin America Sales Analysis
           10.6.1. Overview, Historic and Forecast Sales Analysis
           10.6.2. Latin America by Segment Sales Analysis
           10.6.3. Latin America by Country Sales Analysis
           10.6.4. Brazil Sales Analysis
           10.6.5. Argentina Sales Analysis
           10.6.6. Peru Sales Analysis
           10.6.7. Chile Sales Analysis
           10.6.8. Rest of Latin America Sales Analysis
       10.7. Middle East & Africa Sales Analysis
           10.7.1. Overview, Historic and Forecast Sales Analysis
           10.7.2. Middle East & Africa by Segment Sales Analysis
           10.7.3. Middle East & Africa by Country Sales Analysis
           10.7.4. Saudi Arabia Sales Analysis
           10.7.5. UAE Sales Analysis
           10.7.6. Israel Sales Analysis
           10.7.7. South Africa Sales Analysis
           10.7.8. Rest Of Middle East And Africa Sales Analysis
 
11 . COMPETITIVE LANDSCAPE OF THE RECTO-VAGINAL FISTULA TREATMENT COMPANIES
       11.1. Recto-Vaginal Fistula Treatment Market Competition
       11.2. Partnership/Collaboration/Agreement
       11.3. Merger And Acquisitions
       11.4. New Product Launch
       11.5. Other Developments
 
12 . COMPANY PROFILES OF RECTO-VAGINAL FISTULA TREATMENT INDUSTRY
       12.1. Top Company Share Analysis
       12.2. Market Concentration Rate
       12.3. Pfizer Inc.
           12.3.1. Company Overview
           12.3.2. Company Revenue
           12.3.3. Products
           12.3.4. Recent Developments
       12.4. GlaxoSmithKline plc
           12.4.1. Company Overview
           12.4.2. Company Revenue
           12.4.3. Products
           12.4.4. Recent Developments
       12.5. Sanofi S.A.
           12.5.1. Company Overview
           12.5.2. Company Revenue
           12.5.3. Products
           12.5.4. Recent Developments
       12.6. Takeda Pharmaceutical Company Limited
           12.6.1. Company Overview
           12.6.2. Company Revenue
           12.6.3. Products
           12.6.4. Recent Developments
       12.7. Johnson & Johnson Services Inc.
           12.7.1. Company Overview
           12.7.2. Company Revenue
           12.7.3. Products
           12.7.4. Recent Developments
       12.8. W. L. Gore & Associates Inc.
           12.8.1. Company Overview
           12.8.2. Company Revenue
           12.8.3. Products
           12.8.4. Recent Developments
       12.9. Mount Sinai Hospital
           12.9.1. Company Overview
           12.9.2. Company Revenue
           12.9.3. Products
           12.9.4. Recent Developments
       12.10. Tubingen University Hospital
           12.10.1. Company Overview
           12.10.2. Company Revenue
           12.10.3. Products
           12.10.4. Recent Developments
       12.11. St. Mark's Hospital
           12.11.1. Company Overview
           12.11.2. Company Revenue
           12.11.3. Products
           12.11.4. Recent Developments
       12.12. Apollo Hospitals Enterprise Ltd.
           12.12.1. Company Overview
           12.12.2. Company Revenue
           12.12.3. Products
           12.12.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

 

  •  Market Snapshot
  •  Drivers : Impact Analysis
  •  Restraints : Impact Analysis
  •  List of Raw Material
  •  List of Raw Material Manufactures
  •  List of Potential Buyers
  •  COVID-19 Impact Analysis by Production, Import, Export and Demand
  •  Pre V/S Post COVID-19
  •  Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  •  COVID-19: Micro and Macro Factor Analysis
  •  Analysis by Type (USD MN)
  •  High Recto-vaginal Fistula Market Sales by Geography (USD MN)
  •  Low Recto-vaginal Fistula Market Sales by Geography (USD MN)
  •  Midzone Fistula Market Sales by Geography (USD MN)
  •  Analysis Market by End-user (USD MN)
  •  Hospitals Market Sales by Geography (USD MN)
  •  Ambulatory Surgical Center Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Analysis by Indication (USD MN)
  •  Crohn's Disease Market Sales by Geography (USD MN)
  •  Delivery-related Injuries Market Sales by Geography (USD MN)
  •  Cancerous Tumor Treatment Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Analysis by Treatment (USD MN)
  •  Medication Market Sales by Geography (USD MN)
  •  Antibiotics Market Sales by Geography (USD MN)
  •  Biologics Therapy Market Sales by Geography (USD MN)
  •  Surgery Market Sales by Geography (USD MN)
  •  Sphincteroplasty Procedure Market Sales by Geography (USD MN)
  •  Endorectal Advancement Flap Procedure Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Global Recto-Vaginal Fistula Treatment Market Sales by Geography (USD MN)
  •  North America Market Analysis (USD MN)
  •  United State Market Analysis (USD MN)
  •  Canada Market Analysis (USD MN)
  •  Mexico Market Analysis (USD MN)
  •  Europe Market Analysis (USD MN)
  •  Europe Market Estimate by Country (USD MN)
  •  United Kingdom Market Analysis (USD MN)
  •  France Market Analysis (USD MN)
  •  Germany Market Analysis (USD MN)
  •  Italy Market Analysis (USD MN)
  •  Russia Market Analysis (USD MN)
  •  Spain Market Analysis (USD MN)
  •  Rest of Europe Market Analysis (USD MN)
  •  Asia Pacific Market Analysis (USD MN)
  •  China Market Analysis (USD MN)
  •  Japan Market Analysis (USD MN)
  •  India Market Analysis (USD MN)
  •  South Korea Market Analysis (USD MN)
  •  Australia Market Analysis (USD MN)
  •  Rest of Asia Pacific Market Analysis (USD MN)
  •  Latin America Market Analysis (USD MN)
  •  Brazil Market Analysis (USD MN)
  •  Argentina Market Analysis (USD MN)
  •  Peru Market Analysis (USD MN)
  •  Chile Market Analysis (USD MN)
  •  Rest of Latin America Market Analysis (USD MN)
  •  Middle East & Africa Market Analysis (USD MN)
  •  Saudi Arabia Market Analysis (USD MN)
  •  UAE Market Analysis (USD MN)
  •  Israel Market Analysis (USD MN)
  •  South Africa Market Analysis (USD MN)
  •  Rest of Middle East and Africa Market Analysis (USD MN)
  •  Partnership/Collaboration/Agreement
  •  Mergers And Acquisition
 
 LIST OF FIGURES
 
  •  Research Scope of Recto-Vaginal Fistula Treatment Report
  •  Market Research Process
  •  Market Research Methodology
  •  Global Recto-Vaginal Fistula Treatment Market Size, by Region (USD MN)
  •  Porters Five Forces Analysis
  •  Market Attractiveness Analysis by Type
  •  Market Attractiveness Analysis by End-user
  •  Market Attractiveness Analysis by Indication
  •  Market Attractiveness Analysis by Treatment
  •  Market Attractiveness Analysis by Region
  •  Value Chain Analysis
  •  Global Market Analysis by Type (USD MN)
  •  High Recto-vaginal Fistula Market Sales by Geography (USD MN)
  •  Low Recto-vaginal Fistula Market Sales by Geography (USD MN)
  •  Midzone Fistula Market Sales by Geography (USD MN)
  •  Global Market Analysis by End-user (USD MN)
  •  Hospitals Market Sales by Geography (USD MN)
  •  Ambulatory Surgical Center Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Global Market Analysis by Indication (USD MN)
  •  Crohn's Disease Market Sales by Geography (USD MN)
  •  Delivery-related Injuries Market Sales by Geography (USD MN)
  •  Cancerous Tumor Treatment Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Global Market Analysis by Treatment (USD MN)
  •  Medication Market Sales by Geography (USD MN)
  •  Antibiotics Market Sales by Geography (USD MN)
  •  Biologics Therapy Market Sales by Geography (USD MN)
  •  Surgery Market Sales by Geography (USD MN)
  •  Sphincteroplasty Procedure Market Sales by Geography (USD MN)
  •  Endorectal Advancement Flap Procedure Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Global Market by Revenue
  •  North America Market by Revenue
  •  Europe Market by Revenue
  •  Asia Pacific Market by Revenue
  •  Latin America Market by Revenue
  •  Middle East & Africa Market by Revenue
  •  Recent Development in Industry
  •  Top Company Share Analysis
 
 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials